This site is intended for healthcare professionals

Favourable topline results reported from innovaTV 204 trial of tisotumab vedotin for cervical cancer.- Seattle Genetics + Genmab AS

Read time: 1 mins
Last updated:16th Mar 2021
Published:4th Jul 2020
Condition: Cervical Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest